Chartwell Investment Partners’s Iovance Biotherapeutics IOVA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q4 | – | Sell |
-46,672
| Closed | -$447K | – | 417 |
|
|
2022
Q3 | $447K | Buy |
46,672
+1,635
| +4% | +$15.7K | 0.02% | 390 |
|
|
2022
Q2 | $497K | Buy |
+45,037
| New | +$497K | 0.02% | 395 |
|
|
2021
Q4 | – | Sell |
-60,750
| Closed | -$1.5M | – | 434 |
|
|
2021
Q3 | $1.5M | Buy |
60,750
+12,326
| +25% | +$304K | 0.05% | 335 |
|
|
2021
Q2 | $1.26M | Buy |
+48,424
| New | +$1.26M | 0.04% | 354 |
|
|
2020
Q4 | – | Sell |
-32,633
| Closed | -$1.07M | – | 437 |
|
|
2020
Q3 | $1.07M | Hold |
32,633
| – | – | 0.04% | 341 |
|
|
2020
Q2 | $896K | Sell |
32,633
-34,664
| -52% | -$952K | 0.03% | 341 |
|
|
2020
Q1 | $2.02M | Buy |
67,297
+7,268
| +12% | +$218K | 0.09% | 248 |
|
|
2019
Q4 | $1.66M | Sell |
60,029
-23,076
| -28% | -$639K | 0.05% | 308 |
|
|
2019
Q3 | $1.51M | Sell |
83,105
-52,396
| -39% | -$954K | 0.05% | 341 |
|
|
2019
Q2 | $3.32M | Buy |
+135,501
| New | +$3.32M | 0.11% | 261 |
|